Ironwood Pharmaceuticals Inc (FRA:I76)
€ 4.14 0.04 (0.98%) Market Cap: 649.16 Mil Enterprise Value: 1.13 Bil PE Ratio: 113.00 PB Ratio: 0 GF Score: 49/100

Ironwood Pharmaceuticals Inc Acquires VectivBio Holding AG Call Transcript

May 22, 2023 / 12:30PM GMT
Release Date Price: €9.6 (+0.52%)
Operator

Ladies and gentlemen, good morning. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Ironwood announces acquisition of VectivBio Conference Call. Today's conference is being recorded. (Operator Instructions) Thank you. And I will now turn the conference over to Tom McCourt, Chief Executive Officer. You may begin.

Thomas A. McCourt
Ironwood Pharmaceuticals, Inc. - CEO & Director

Thanks, Abby, and good morning or good afternoon, everyone. I'm Tom McCourt, Chief Executive Officer of Ironwood Pharmaceuticals, and I'm delighted that you've joined us today as we take you through this exciting announcement in our agreement to acquire VectivBio.

Before I continue, please take a moment to review our safe harbor statement on Slide 2. Joining me today are Sravan Emany, Ironwood's Chief Financial Officer; Mike Shetzline, our Chief Medical Officer; Andrew Davis, our Chief Business Officer; and following our remarks, we will open the call with a question-and-answer session. As was highlighted

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot